Cargando…

How Should We Classify Kawasaki Disease?

The exact classification of Kawasaki disease (KD) has been debated. Infectious disease specialists have claimed it as an infection with a classic immune responses to an as yet unidentified pathogen that localizes to the coronary arteries. Others have favored an autoreactive hypothesis that KD is tri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marrani, Edoardo, Burns, Jane C., Cimaz, Rolando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302019/ https://www.ncbi.nlm.nih.gov/pubmed/30619331 http://dx.doi.org/10.3389/fimmu.2018.02974

Ejemplares similares

Kawasaki shock syndrome: a case report
por: Marrani, Edoardo, et al.
Publicado: (2014)

Chapter 11 Kawasaki Disease
por: Falcini, Fernanda, et al.
Publicado: (2007)

Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic
por: Koné-Paut, Isabelle, et al.
Publicado: (2020)

Kawasaki disease in Sicily: clinical description and markers of disease severity
por: Maggio, Maria Cristina, et al.
Publicado: (2016)

Eradicating Infectious Disease: Can We and Should We?
por: Russell, Clark Donald
Publicado: (2011)

Editorial: Pathogenesis, Clinical Findings, and Treatment Advances in Kawasaki Disease
por: Giani, Teresa, et al.
Publicado: (2021)

How Should We Classify Patients Who Have Spondylitis and Psoriasis?
por: Baek, Han Joo
Publicado: (2022)

Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease
por: Galeotti, Caroline, et al.
Publicado: (2016)

Extensive Ethnic Variation and Linkage Disequilibrium at the FCGR2/3 Locus: Different Genetic Associations Revealed in Kawasaki Disease
por: Nagelkerke, Sietse Q., et al.
Publicado: (2019)

Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic
por: Harahsheh, Ashraf S., et al.
Publicado: (2020)

Finding Kawasaki disease
por: Burns, Jane C
Publicado: (2012)

COVID-19 and Kawasaki syndrome: should we really be surprised?
por: Loomba, Rohit S., et al.
Publicado: (2020)

Pathogénie de la maladie de Kawasaki : quoi de neuf ?
por: Belot, Alexandre, et al.
Publicado: (2012)

Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review
por: Ferrara, Giovanna, et al.
Publicado: (2020)

Brainstem Auditory Evoked Potentials and Visual Potentials in Kawasaki Disease: An Observational Monocentric Study
por: Maggio, Maria Cristina, et al.
Publicado: (2020)

Sensorineural hearing loss: a new manifestation of neonatal lupus erythematosus?
por: Pagnini, Ilaria, et al.
Publicado: (2014)

Kawasaki disease: an epidemiological study in central Italy
por: Mauro, Angela, et al.
Publicado: (2016)

Previous or coincident infections with suspected Kawasaki disease. Should we change our approach?()()
por: Fernández-Cooke, Elisa, et al.
Publicado: (2019)

The role of mitochondria in the pathogenesis of Kawasaki disease
por: Beckley, Mikayla A., et al.
Publicado: (2022)

Localized scleroderma in a cohort of juvenile idiopathic arthritis children
por: Giani, Teresa, et al.
Publicado: (2014)

SARS-COV-2 Infection and Kawasaki Disease: Case Report of a Hitherto Unrecognized Association
por: Cazzaniga, Marco, et al.
Publicado: (2020)

Immunity to Avian Leukosis Virus: Where Are We Now and What Should We Do?
por: Feng, Min, et al.
Publicado: (2016)

Kawasaki Disease: The Role of Immune Complexes Revisited
por: Menikou, Stephanie, et al.
Publicado: (2019)

How should we conduct pandemic vaccination?
por: Williams, Jane, et al.
Publicado: (2021)

Management of sequelae of Kawasaki disease in adults
por: Gordon, John B., et al.
Publicado: (2017)

Single center blind testing of a US multi-center validated diagnostic algorithm for Kawasaki disease in Taiwan
por: Kuo, Ho-Chang, et al.
Publicado: (2022)

P114 How should we classify on-call workers? A proposed taxonomy for modern working arrangements
por: Sprajcer, M, et al.
Publicado: (2022)

Frequently asked questions regarding treatment of Kawasaki disease
por: Burns, Jane C.
Publicado: (2017)

Kawasaki disease in infants less than one year of age: an Italian cohort from a single center
por: Mastrangelo, Greta, et al.
Publicado: (2019)

Commentary: Why should we classify damage control in cardiac surgery?
por: Haaverstad, Rune, et al.
Publicado: (2021)

“Brucellupus” in a boy: challenging sle diagnosis in childhood
por: Paganelli, Valeria, et al.
Publicado: (2014)

Revisiting Once Again Steroids for the Treatment of Acute Kawasaki Disease
por: Burns, Jane C.
Publicado: (2020)

Increased percentages of calprotectin and TNF-Α double-positive monocytes in the acute phase of Kawasaki disease
por: Cimaz, Rolando, et al.
Publicado: (2011)

MicroRNAs in Kawasaki disease: An update on diagnosis, therapy and monitoring
por: Xiong, Yiyi, et al.
Publicado: (2022)

Dysbiosis of the gut microbiota as a susceptibility factor for Kawasaki disease
por: Teramoto, Yoshiki, et al.
Publicado: (2023)

How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?
por: Murakami, Naoya, et al.
Publicado: (2022)

How do we and how should we deal with uncertainty in endodontics?
por: Pigg, Maria, et al.
Publicado: (2022)

Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease
por: Piram, Maryam, et al.
Publicado: (2020)

Clinical Use and Molecular Action of Corticosteroids in the Pediatric Age
por: Ferrara, Giovanna, et al.
Publicado: (2019)

Bridging a diagnostic Kawasaki disease classifier from a microarray platform to a qRT-PCR assay
por: Kuiper, Rowan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ksh7a016jhhaf8j3pjmfesqppa